We hypothesize that human leptin has key roles in the regulation of endocrine and metabolic function. The goal of this hypothesis-driven, patient oriented study is to elucidate the endocrine (and metabolic) long-term effects of human leptin. This is a competitive renewal of a study in which we recruited and are currently providing leptin replacement treatment to the only adult individuals identified in the world so far who have a genetically-based, complete deficiency of leptin. These individuals, from a large and highly consanguineous Turkish pedigree, are homozygous for a leptin gene mutation consisting of a C_T substitution in codon 105 of the leptin gene, resulting in an Arg_Trp replacement in the mature protein. This causes a premature stop codon and leads to the same aminoacid substitution as that found in the leptin gene of the ob/ob mouse. Individuals who are homozygous for this mutation are morbidly obese and hypogonadic. As they receive leptin replacement, patients are undergoing weight loss, with marked increases in 24-h fat oxidation. They also have evidence of clinical improvement in endocrine function. This application brings together four research groups with an outstanding history of productive collaborations: Julio Licinio, M.D., UCLA, will oversee the continued longitudinal leptin replacement treatment of these subjects and will conduct rigorous and detailed neuroendocrine studies. Eric Ravussin, Ph.D., Pennington Biomedical Research Center, will study metabolic function. Johannes D. Veldhuis, M.D., University of Virginia, will provide expertise in endocrine data analysis. Metin Ozata, M.D., Gulhane Medical School, Ankara, Turkey, will oversee patients' treatment and health care while they are in Turkey. This study will make it possible for this highly experienced and crossdisciplinary group of investigators to rigorously assess the long-term effects of human leptin in the only adult subjects identified so far who are homozygous for a functional leptin gene mutation. This unique experimental paradigm can contribute to elucidate important aspects of the biology of human leptin. Discontinuation of this study would be highly deleterious, not only for the patients, but also for our understanding of the long-term effects of leptin in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK058851-04
Application #
6726835
Study Section
Endocrinology Study Section (END)
Program Officer
Sato, Sheryl M
Project Start
2000-12-15
Project End
2006-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
4
Fiscal Year
2004
Total Cost
$342,663
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Paz-Filho, Gilberto; Mastronardi, Claudio A; Licinio, Julio (2015) Leptin treatment: facts and expectations. Metabolism 64:146-56
Licinio, J; Negrao, A B; Wong, M-L (2014) Plasma leptin concentrations are highly correlated to emotional states throughout the day. Transl Psychiatry 4:e475
Berman, Steven M; Paz-Filho, Gilberto; Wong, Ma-Li et al. (2013) Effects of leptin deficiency and replacement on cerebellar response to food-related cues. Cerebellum 12:59-67
Ishibashi, K; Berman, S M; Paz-Filho, G et al. (2012) Dopamine D2/D3 receptor availability in genetically leptin-deficient patients after long-term leptin replacement. Mol Psychiatry 17:352-3
London, Edythe D; Berman, Steven M; Chakrapani, Shruthi et al. (2011) Short-term plasticity of gray matter associated with leptin deficiency and replacement. J Clin Endocrinol Metab 96:E1212-20
Paz-Filho, Gilberto; Mastronardi, Claudio; Delibasi, Tuncay et al. (2010) Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy. Arq Bras Endocrinol Metabol 54:690-7
Galgani, Jose E; Greenway, Frank L; Caglayan, Sinan et al. (2010) Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptin-deficient patients. J Clin Endocrinol Metab 95:851-5
Paz-Filho, G; Wong, M-L; Licinio, J (2010) The procognitive effects of leptin in the brain and their clinical implications. Int J Clin Pract 64:1808-12
Paz-Filho, Gilberto Jorge; Delibasi, Tuncay; Erol, Halil Kutlu et al. (2009) Cellular immunity before and after leptin replacement therapy. J Pediatr Endocrinol Metab 22:1069-74
Paz-Filho, G J; Andrews, D; Esposito, K et al. (2009) Effects of leptin replacement on risk factors for cardiovascular disease in genetically leptin-deficient subjects. Horm Metab Res 41:164-7

Showing the most recent 10 out of 34 publications